Last reviewed · How we verify
NCT06076564: LASSO
Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality
trial in Stimulant Overdose in 176 participants. Completed in 12 February 2024.
12 February 2024
Quick facts
| Lead sponsor | San Francisco Department of Public Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 176 |
| Start date | 6 June 2022 |
| Primary completion | 12 February 2024 |
| Estimated completion | 12 February 2024 |
| Sites | 1 location across United States |
Conditions studied
- Stimulant Overdose — all drugs for Stimulant Overdose →
- Overdose Accidental — all drugs for Overdose Accidental →
- Overdose Cocaine — all drugs for Overdose Cocaine →
- Overdose Methamphetamine — all drugs for Overdose Methamphetamine →
Sponsor
San Francisco Department of Public Health
Who can join
18 and older, any sex, with Stimulant Overdose or Overdose Accidental. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the LASSO study, the investigators will identify 100 stimulant overdose decedents (divided among stimulant-only, and stimulant with fentanyl), conduct informant interviews (including scales and qualitative data), and gather data from the postmortem investigation (e.g., vital records, toxicology, autopsy, case narrative, death scene photographs) and medical record abstraction. Subsequently, study staff will conduct qualitative interviews with 40-60 living people who use stimulants (aiming for half methamphetamine, half cocaine) to explore elements of resilience and risk reduction strategies. This study aims to contribute to the eventual design of interventions to reduce stimulant overdose mortality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06076564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other San Francisco Department of Public Health trials
Trials by the same sponsor.
- NCT07219082 — Behavioral Safety and Fentanyl Education: BSAFE · NA · not yet recruiting
- NCT07204249 — Glutide for Ending Methamphetamine · Phase 2 · not yet recruiting
- NCT04614584 — Mirtazapine and Methamphetamine Drug-drug Interaction Study · Phase 1 · completed
- NCT03838510 — Repeated-dose Behavioral Intervention to Reduce Opioid Overdose · NA · completed
- NCT03018353 — Curing HCV in Incarcerated Patients · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06076564 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by San Francisco Department of Public Health
- Last refreshed: 27 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06076564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing